Trusted by Australian brands






































You've invested millions in R&D, navigated TGA approval, and built a device that genuinely improves patient outcomes - but hospitals aren't adopting it. Your sales team can't get past procurement gatekeepers, physicians are sceptical of anything that disrupts their workflow, and your competitors' inferior devices are winning because they've built awareness you haven't. At Odin Digital, our medical device SEO and LinkedIn HCP targeting strategies are built specifically for the complex, multi-stakeholder healthcare buying cycle.
The Medical Device Companies Marketing Challenge.
You have a TGA-approved device that could transform patient outcomes, but hospitals aren't adopting it. Your sales cycle stretches 12-18 months. Physicians are sceptical of anything new.
- You're invisible to the physicians, surgeons, and procurement committees who make buying decisions
- Your clinical evidence and outcome data isn't reaching the right decision-makers at the right time
- Incumbent device manufacturers have entrenched relationships you can't break through cold outreach
- Your sales team spends 80% of their time educating prospects instead of closing - because marketing hasn't built awareness
- Reimbursement uncertainty and workflow disruption concerns are killing deals before they start
Medical device adoption doesn't happen through cold calls and trade show booths - it happens through clinical education, peer influence, and systematic demand generation that builds trust before your sales team ever picks up the phone.
Where Data Finds
its Voice.
Why Medical Device Marketing Requires a Fundamentally Different Approach
Generic marketing agencies don't understand this ecosystem - and the cost of getting it wrong is measured in years of lost adoption.
Medical device marketing isn't B2B marketing with a healthcare label. It's a uniquely complex discipline that involves multiple stakeholders (physicians, surgeons, hospital administrators, procurement committees, biomedical engineers), regulatory constraints (TGA, AHPRA advertising guidelines), long sales cycles (6-18 months), and decisions that directly impact patient outcomes. Generic marketing agencies don't understand this ecosystem - and the cost of getting it wrong is measured in years of lost adoption.
The core challenge: physicians are inherently conservative. They won't adopt a new device based on a LinkedIn ad or a glossy brochure. They need peer-reviewed evidence, hands-on experience, and validation from trusted colleagues (KOLs) before they'll change their practice. Your marketing must mirror this decision process - providing the right evidence, to the right stakeholder, at the right stage of their evaluation journey.
We build medical device marketing systems that respect the clinical buying cycle while accelerating it, moving physicians from awareness to evaluation to adoption through systematic education, peer influence, and evidence-based demand generation.
Why Medical Device Companies Choose Odin Digital.
The Art: Industry-Specific Strategy
Clinical storytelling that translates complex trial data into compelling adoption narratives, peer-influence campaigns that build trust through KOL validation, and brand positioning that establishes your device as the standard-of-care.
The Science: Data-Driven Optimisation
Multi-stakeholder targeting across physicians, administrators, and procurement committees, automated nurture sequences that match the 6-18 month evaluation cycle, and pipeline attribution that connects marketing to device adoption outcomes.
We partner with medical device companies that have life-changing technology but struggle to break through clinical inertia - building systematic demand generation engines that accelerate adoption from TGA approval to standard-of-care.
KOL Engagement and Peer Influence: The Engine That Drives Clinical Adoption
Your KOL strategy isn't a nice-to-have - it's the foundation of your entire go-to-market approach.
In medical device adoption, the opinion of a single Key Opinion Leader (KOL) carries more weight than a $500K advertising campaign. Physicians trust their peers. They attend conferences to hear what colleagues are using, they read case studies from respected practitioners, and they adopt technologies that KOLs in their specialty have validated. Your KOL strategy isn't a nice-to-have - it's the foundation of your entire go-to-market approach.
We help medical device companies build systematic KOL engagement programs: identifying and mapping the influence networks in your target specialty, developing co-authored content and case study programs, creating speaking opportunity pipelines at relevant conferences and grand rounds, and building digital amplification strategies that extend KOL voices across LinkedIn, medical publications, and educational webinars.
The goal isn't just endorsement, it's creating a peer-influence cascade where early adopters become advocates, advocates become educators, and educators drive mainstream adoption. This is how category-defining devices go from niche to standard-of-care.

Our Marketing Process for Medical Device Companies.
Clinical Education & KOL Engagement
Evidence-based content ecosystems and systematic KOL programs that build peer-validated credibility and drive physician adoption through clinical trust.
Multi-Stakeholder Demand Generation
Precision targeting of physicians, administrators, and procurement committees with role-specific content that moves devices through evaluation to adoption.
Health Economics & Value Communication
HEOR marketing materials, reimbursement guides, and cost-effectiveness analyses that remove the economic barriers standing between your device and adoption.
LinkedIn Advertising for Medical Devices: Precision Targeting of Healthcare Decision-Makers
multi-touch campaigns
LinkedIn is the single most effective digital channel for reaching healthcare professionals, hospital administrators, and procurement decision-makers. Unlike consumer platforms, LinkedIn allows you to target by specialty, hospital affiliation, seniority level, and professional interest - putting your clinical evidence directly in front of the people who influence and approve device purchases.
Our medical device LinkedIn strategy goes beyond basic sponsored posts. We build multi-touch campaigns that mirror the clinical evaluation cycle: awareness-stage content (clinical outcome data, peer-reviewed summaries), consideration-stage content (case studies, comparison data, health economics analysis), and decision-stage content (trial program invitations, product demonstrations, consultation requests).
Combined with LinkedIn's conversation ads for direct HCP engagement, lead gen forms that capture specialty and institution data, and retargeting sequences that nurture prospects over months - we build a systematic pipeline that delivers qualified leads to your sales team with clinical context attached. No more cold outreach to physicians who've never heard of your device.
Medical Device Marketing: Odin Digital vs. Generic Agencies
Clinical Evidence Marketing: Translating Data Into Adoption-Driving Narratives
compelling, accessible narratives
Your clinical trial data is your most valuable marketing asset - but raw data doesn't drive adoption. What drives adoption is translating that data into compelling, accessible narratives that answer the three questions every physician asks: Does it improve patient outcomes? Does it fit my workflow? Does it make economic sense for my practice or hospital?
We create evidence-based content ecosystems that communicate your clinical story across every touchpoint: executive summaries that distil complex trial data into scannable key findings, visual infographics that make outcome comparisons instantly understandable, video testimonials from early-adopting physicians discussing real-world clinical experience, and long-form white papers that satisfy the most rigorous clinical evaluation.
Every piece is designed for dual audiences: the clinician who needs outcome data and the administrator who needs health economics. We also ensure all content is structured for medical-legal review, with proper citation of approved indications, clinical references, and regulatory disclaimers - so your marketing team isn't bottlenecked by compliance review cycles.
Your FREE Strategy Session Includes:
Multi-stakeholder targeting strategy for physicians, administrators, and procurement committees
KOL identification, engagement program design, and peer-influence amplification
LinkedIn HCP campaigns targeting by specialty, institution, and seniority
Evidence-based content ecosystems translating clinical data into adoption narratives
Health economics and reimbursement marketing materials for procurement approval
Conference marketing integration (pre/during/post event digital campaigns)
SEO strategy targeting clinical, procurement, and patient-driven search intent
Multi-stakeholder email nurture sequences for 6-18 month evaluation cycles
TGA/AHPRA-compliant content frameworks with pre-approved claim libraries
Pipeline attribution reporting connecting marketing to device evaluation and adoption
No credit card required · Response within 24 hours
Hit Your KPIs in 90 Days or We Work for Free.
If we don't deliver a measurable increase in qualified HCP leads and sales pipeline acceleration within 90 days, we'll work for free until we do. We only win when your device is being adopted by the clinicians who need it.
No long-term contracts · No hidden fees · Just results
Health Economics and Reimbursement Marketing: Removing the Biggest Barrier to Adoption
If you can't communicate economic value clearly, your device will die in committee review regardless of clinical merit.
The most common reason medical devices fail to achieve adoption isn't clinical - it's economic. Hospital administrators need to justify the capital expenditure. Procurement committees need to understand total cost of ownership. Physicians need to know their patients' procedures will be reimbursed. If you can't communicate economic value clearly, your device will die in committee review regardless of clinical merit.
We build health economics and outcomes research (HEOR) marketing materials that make the financial case irrefutable: total cost-of-ownership analyses comparing your device to current standard-of-care, per-procedure cost breakdowns including consumables and training, workflow efficiency gains measured in time-per-procedure and throughput improvements, length-of-stay reductions and complication rate improvements that translate to hospital savings, and reimbursement guides with CPT/MBS code mapping and payer coverage summaries.
These materials don't just support your sales team - they arm your internal champion (the physician advocate) with the economic ammunition they need to push your device through procurement approval.
SEO for Medical Devices: Capturing Clinical and Procurement Search Intent
clinical search
When a surgeon searches 'minimally invasive [procedure] device comparison' or a hospital administrator searches '[device category] cost-effectiveness analysis,' your company needs to appear with authoritative, evidence-based content. Medical device SEO is fundamentally different from consumer SEO - it targets a small, highly specialised audience making high-value decisions.
Our medical device SEO strategy targets three distinct search intent categories: clinical search (procedure-specific, outcome-focused queries from physicians), procurement search (cost comparison, vendor evaluation, and specification queries from administrators), and patient-driven search (treatment option queries that create downstream demand from patients asking their doctors about your technology).
Each category gets dedicated content optimised with medical terminology, clinical references, and schema markup that helps search engines understand the E-E-A-T authority of your content. Combined with technical SEO that ensures your clinical resources, white papers, and case studies are properly indexed and discoverable, we build long-term organic visibility that compounds into a sustainable source of qualified HCP leads.
Conference and Event Marketing: Extending Your Physical Presence Digitally
The ROI on conference investment increases 3-5x when you integrate digital marketing before, during, and after the event.
Medical conferences remain the primary venue for device discovery and evaluation. But most device companies treat conferences as standalone events - investing $50K-$200K in a booth, collecting business cards, and hoping leads convert months later. The ROI on conference investment increases 3-5x when you integrate digital marketing before, during, and after the event.
Our conference marketing framework includes pre-event LinkedIn campaigns targeting registered attendees, appointment-setting outreach to priority HCPs, live social coverage and thought leadership content during the event, and post-event nurture sequences that maintain engagement with every lead captured - segmented by specialty, interest level, and evaluation stage.
We also build evergreen content from conference presentations: recording and repurposing keynotes, panel discussions, and product demonstrations into on-demand webinars, social clips, and educational resources that extend the value of your conference investment year-round. Your $100K conference booth shouldn't generate value for just 3 days - it should fuel your marketing engine for 12 months.
Web Design for Medical Device Companies: Building Clinical Credibility Online
dual-audience architecture
Your website isn't a brochure - it's your most important sales tool. When a physician is evaluating your device, they will visit your website to review clinical data, compare specifications, and assess your company's credibility. If your site looks like a generic corporate template with stock photos and vague claims, you've lost the sale before your rep gets a meeting.
Our medical device web design builds sites with dual-audience architecture: clinical portals for HCPs (with gated access to clinical data, peer-reviewed publications, and case studies) and patient-facing sections (with treatment information that creates downstream demand). Each device or product line gets a dedicated hub with technical specifications, clinical evidence summaries, training resources, and clear pathways to request demonstrations or clinical evaluations.
We also build resource centres that serve as clinical education hubs - hosting webinar recordings, white papers, surgical technique guides, and KOL interviews. These resources become your most powerful SEO assets while simultaneously serving as sales enablement tools that your reps can share during the evaluation process.
Multi-Stakeholder Nurture: Managing the 6-18 Month Device Evaluation Cycle
Your marketing must speak to all of them simultaneously while maintaining message consistency.
Medical device purchasing isn't a single decision - it's a committee process involving clinicians, biomedical engineers, administrators, procurement officers, and sometimes patients. Each stakeholder has different concerns, different information needs, and different timelines. Your marketing must speak to all of them simultaneously while maintaining message consistency.
We build multi-stakeholder nurture programs with segmented email sequences tailored to each decision-maker's role: clinicians receive clinical outcome data and peer case studies; administrators receive health economics analyses and ROI projections; biomedical engineers receive technical specifications and integration documentation; procurement receives pricing, service agreements, and vendor comparison frameworks.
Combined with CRM integration that tracks engagement across all stakeholders within a single account, your sales team gets a real-time view of where each hospital sits in their evaluation process - and your marketing automatically delivers the right content to move stalled deals forward. This systematic approach typically reduces sales cycle length by 20-30%.
Regulatory-Compliant Content at Scale: Marketing Without Bottlenecks
Most marketing teams are bottlenecked not by ideas, but by the review-and-approval cycle that turns a 2-week campaign into a 3-month project.
The biggest operational challenge in medical device marketing isn't creative - it's compliance. Every claim must be supported by approved indications. Every testimonial must meet TGA advertising standards. Every piece of content must pass medical-legal review before publication. Most marketing teams are bottlenecked not by ideas, but by the review-and-approval cycle that turns a 2-week campaign into a 3-month project.
We solve this by building compliance-first content systems: templated content frameworks pre-approved by your medical-legal team, modular claim libraries with pre-cleared language for each approved indication, standardised review workflows that route content to the right reviewers with clear approval criteria, and a content bank of approved assets that can be rapidly assembled into new campaigns without restarting the review process.
The result: your marketing velocity increases 3-4x without compromising compliance. New campaigns launch in days instead of months. Your regulatory team reviews less because more content is built from pre-approved modules. And your competitive position improves because you can respond to market opportunities while competitors are still stuck in review cycles.
Services That Drive Results for Medical Device Companies.
LinkedIn Advertising
Precision-target physicians and procurement teams at hospitals and health systems.
Learn moreSearch Engine Optimisation
Build clinical authority for device-specific and procedure-related searches.
Learn moreWeb Design & Development
Dual-audience platforms with clinical portals and patient-facing content.
Learn moreEmail Marketing
Multi-stakeholder nurture sequences for 6-18 month evaluation cycles.
Learn moreWe Also Specialise In
From Google Ads campaigns targeting procedure-specific clinical searches to email nurture sequences that educate procurement committees over 6-12 month cycles, our medical device marketing systems are designed to accelerate adoption - not just generate impressions. Combined with evidence-based web design and targeted social campaigns, we build the complete clinical demand engine that turns TGA approval into market penetration.
Common Questions
Medical Device Companies Digital Marketing FAQs
All content is built compliance-first. We create templated frameworks with pre-approved claim libraries for each approved indication, modular content systems that reduce review cycles, and standardised workflows for medical-legal approval. Every claim is supported by clinical evidence, and every piece is structured for rapid regulatory review. This approach increases marketing velocity 3-4x without compromising compliance.
Through multi-channel HCP targeting: LinkedIn campaigns targeting by specialty and institution, placements in medical publications and educational platforms, KOL-driven content and peer-to-peer education programs, and conference integration strategies. We also build clinical education content (webinars, case studies, outcome summaries) that physicians actively seek out - pulling them to your brand rather than pushing ads at them.
We build comprehensive HEOR marketing materials: total cost-of-ownership analyses vs. standard-of-care, per-procedure cost breakdowns, workflow efficiency gains, complication rate reductions, and reimbursement guides with CPT/MBS code mapping. These materials arm your internal champion with the economic evidence needed to push devices through procurement committee approval.
LinkedIn and Google Ads can generate qualified HCP leads within 30-60 days. KOL engagement programs show influence within 90 days. SEO authority builds over 3-6 months. Full adoption acceleration compounds over 6-12 months as education, peer influence, and clinical evidence create a self-reinforcing demand cycle. We report on leading indicators (engagement, lead quality, pipeline stage progression) from day one.
Through account-based marketing (ABM) with CRM integration. We map decision-makers within target institutions, create role-specific content sequences (clinical data for physicians, HEOR for administrators, specs for biomedical engineers, pricing for procurement), and track engagement across all stakeholders within a single account. Your sales team sees a real-time view of where each institution sits in evaluation.
Critical. A single KOL endorsement carries more weight than a $500K advertising campaign. We build systematic KOL programs: identification and influence mapping, co-authored case studies, speaking opportunity pipelines, digital amplification of KOL content, and advisory board structuring. The goal is creating peer-influence cascades where early adopters become advocates who drive mainstream adoption.
Yes. We build dual-audience architectures: clinical portals with gated access to evidence and case studies for HCPs, and patient-facing content that creates downstream demand (patients asking their doctors about your technology). Patient awareness campaigns are particularly effective for elective-procedure devices where patient demand directly influences physician adoption.
Beyond standard metrics (impressions, clicks, leads), we track pipeline-specific KPIs: qualified HCP leads by specialty and institution, sales cycle stage progression, content engagement by stakeholder role, conference lead conversion rates, and marketing-influenced pipeline value. The goal is connecting marketing activity directly to device evaluation requests and adoption outcomes.
Conference marketing should generate ROI for 12 months, not 3 days. We run pre-event LinkedIn campaigns targeting attendees, appointment-setting outreach to priority HCPs, live social coverage during events, and post-event nurture sequences for every lead captured. We also repurpose presentations and demos into on-demand webinars and educational content that extends your conference investment year-round.
Most growth-stage device companies invest 10-20% of revenue in marketing, with allocation depending on lifecycle stage. Pre-launch focuses on KOL engagement and clinical education. Launch-stage allocates heavily to awareness (LinkedIn, conferences, SEO). Growth-stage shifts toward demand generation and sales enablement. We recommend a minimum of $8,000-$15,000/month in combined ad spend and management for meaningful HCP pipeline development.



